001     189312
005     20220930130041.0
024 7 _ |a 10.1002/mds.26229
|2 doi
024 7 _ |a WOS:000357945600018
|2 WOS
024 7 _ |a altmetric:3964631
|2 altmetric
024 7 _ |a pmid:25914247
|2 pmid
037 _ _ |a FZJ-2015-02490
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Weiss-Blankenhorn, Peter
|0 P:(DE-Juel1)131748
|b 0
|e Corresponding author
245 _ _ |a Subthalamic nucleus stimulation improves Parkinsonian gait via brainstem locomotor centers
260 _ _ |a New York, NY
|c 2015
|b Wiley
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1438772901_16993
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a Subthalamic deep brain stimulation (STN-DBS) can ameliorate gait disturbances in Parkinson's disease (PD). Using motor imagery and positron emission tomography (PET), we investigated how STN-DBS interacts with supraspinal locomotor centers in PD.Ten PD patients with bilateral STN-DBS actually walked or stood still under STN-DBS ON or OFF conditions. Directly thereafter, subjects imagined walking or standing while changes in regional cerebral blood flow were measured by PET.Independent of STN-DBS, imagined walking distance correlated with imagery duration. Compared with STN-DBS OFF, STN-DBS ON improved actual gait and increased imagined walking distance. Imagery of gait (vs. stance) induced activity in the supplementary motor area and the right superior parietal lobule for both STN-DBS conditions. The improvement of imagined gait during STN-DBS ON led to activity changes in the pedunculopontine nucleus/mesencephalic locomotor region (PPN/MLR).Data suggest that STN-DBS improves Parkinsonian gait by modulating PPN/MLR activity. © 2015 International Parkinson and Movement Disorder Society
536 _ _ |a 572 - (Dys-)function and Plasticity (POF3-572)
|0 G:(DE-HGF)POF3-572
|c POF3-572
|f POF III
|x 0
700 1 _ |a Herzog, J.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Pötter-Nerger, M.
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Falk, D.
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Herzog, Hans
|0 P:(DE-Juel1)131768
|b 4
700 1 _ |a Deuschl, G.
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Volkmann, J.
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Fink, Gereon Rudolf
|0 P:(DE-Juel1)131720
|b 7
773 _ _ |a 10.1002/mds.26229
|0 PERI:(DE-600)2041249-6
|n 8
|p 1121 – 1125
|t Movement disorders
|v 30
|y 2015
|x 0885-3185
856 4 _ |u https://juser.fz-juelich.de/record/189312/files/Weiss_et_al-2015-Movement_Disorders.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/189312/files/Weiss_et_al-2015-Movement_Disorders.gif?subformat=icon
|x icon
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/189312/files/Weiss_et_al-2015-Movement_Disorders.jpg?subformat=icon-1440
|x icon-1440
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/189312/files/Weiss_et_al-2015-Movement_Disorders.jpg?subformat=icon-180
|x icon-180
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/189312/files/Weiss_et_al-2015-Movement_Disorders.jpg?subformat=icon-640
|x icon-640
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/189312/files/Weiss_et_al-2015-Movement_Disorders.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |o oai:juser.fz-juelich.de:189312
|p VDB
|p OpenAPC
|p openCost
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)131748
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)131768
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 7
|6 P:(DE-Juel1)131720
913 0 _ |a DE-HGF
|b Gesundheit
|l Funktion und Dysfunktion des Nervensystems
|1 G:(DE-HGF)POF2-330
|0 G:(DE-HGF)POF2-333
|2 G:(DE-HGF)POF2-300
|v Pathophysiological Mechanisms of Neurological and Psychiatric Diseases
|x 0
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-572
|2 G:(DE-HGF)POF3-500
|v (Dys-)function and Plasticity
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2015
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MOVEMENT DISORD : 2013
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b MOVEMENT DISORD : 2013
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
920 1 _ |0 I:(DE-Juel1)INM-4-20090406
|k INM-4
|l Physik der Medizinischen Bildgebung
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a I:(DE-Juel1)INM-4-20090406
980 _ _ |a UNRESTRICTED
980 _ _ |a APC
981 _ _ |a I:(DE-Juel1)INM-4-20090406


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21